Results

Total Results: 258 records

Showing results for "end stage renal".

21. Screening for and Management of Chronic Kidney Disease Stages 1-3 | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research-protocol
    July 28, 2010 - respectively, compared with 1995. 5 It has been estimated that more than 700,000 individuals will have end-stage … for each question Benefits Clinical outcomes: Reduced mortality Reduced/delayed incidence of end-stage … for each question Benefits Clinical outcomes: Reduced mortality Reduced/delayed incidence of end-stage … Projecting the number of patients with end-stage renal disease in the United States to the year 2015. … dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage

22. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - Published Online: July 28, 2010 3 been estimated that more than 700,000 individuals will have end-stage … each question Benefits - Clinical outcomes:  Reduced mortality  Reduced/delayed incidence of end-stage … each question Benefits - Clinical outcomes:  Reduced mortality  Reduced/delayed incidence of end-stage … each question Benefits - Clinical outcomes:  Reduced mortality  Reduced/delayed incidence of end-stage … Projecting the number of patients with end-stage renal disease in the United States to the year 2015

23. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/renal-mass-and-localized-renal-cancer-the-following-questions-are-recommended-to-address-the-healthcare-tests-andor-treatments-this-program-should-consider-what-indicators-can-be-used-to-predict-malignancy-andor-aggressivenes
    October 24, 2013 - Indicators for renal cell cancer therapy include stage (based on the TNM classification system), as well … Patients in end stage renal disease also appear to be at increased risk for renal cancer, which has important … The AUA first developed a Guideline for the Management of the Clinical Stage 1 Renal Mass in 2009. … cancer beyond clinical stage 1. … In addition to the subject matter encompassed by the current Clinical Stage 1 Renal Mass guideline, the

24. Treatment Intensification in Type 2 Diabetes Mellitus | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-treatment/abstract
    January 24, 2012 - alone Outcomes – a) development of CVD (acute myocardial infarction and stroke), CKD (including End … Stage Renal Disease), and death from all causes in individuals without CVD and CKD; b) progression of … CVD (acute myocardial infarction and stroke), CKD (including End Stage Renal Disease), and death from

25. Laboratory Biomarkers for Iron Deficiency Anemia in Late Stage Chronic Kidney Disease | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/chronic-kidney-disease-anemia-2011/research-protocol
    August 29, 2011 - When CKD progresses to its end stage, it would necessitate dialysis or kidney transplantation. … United States Renal Data System. 2010 USRDS Annual Data Report: Vol. 2 Atlas of End-Stage Renal Disease … The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. … Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

26. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
    January 01, 2011 - When CKD progresses to its end stage, it would necessitate dialysis or kidney transplantation. … United States Renal Data System. 2010 USRDS Annual Data Report: Vol. 2 Atlas of End-Stage Renal Disease … The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. … Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease … Key Informants Key Informants are the end users of research, including patients and caregivers,

27. Kidney-Disease-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
    October 01, 2012 - =Congestive Heart Failure; CKD=Chronic Kidney Disease; eGFR=Epidermal growth factor receptor; ESRD=End-Stage … The primary composite end point occurred in 26 patients in the sulodexide group and 30 patients in … 1 or 2 eGFR Indices of kidney injury 30 days Indices of kidney injury were not changed in Stage 1 … However, stage 2 patients decreased urinary albumin, N-acetyl B-D- glucosaminidase and transforming … =Congestive Heart Failure; CKD=Chronic Kidney Disease; eGFR=Epidermal growth factor receptor; ESRD=End-Stage

28. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
    August 01, 2012 - Evidence that screening is ineffective The draft CER focuses on endpoints for end-stage renal disease … Chronic Kidney Disease‖ American Journal of Medicine (2007) 120, 280.e1-280.e7 (4) Incidence of End-Stage … Minority populations with CKD have more rapid progression to end-stage renal disease (ESRD), which results … ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop; a post … The draft CER focuses on endpoints for end-stage renal disease (ESRD), cardiovascular disease (CVD)

29. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0398_06-17-2008.pdf
    January 01, 2008 - Topic Selection Process & Next Steps  Biomarkers to guide treatment for iron-deficiency anemia in renal … Biomarkers to Guide Treatment for Iron-Deficiency Anemia in Renal Dialysis Patients Nomination Summary … )  Anemia in patients with end-stage renal disease (ESRD) is a risk factor for increased mortality

30. Prevention of Contrast Media Induced Nephropathy | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/nephropathy-contrast-induced/research-protocol
    November 12, 2013 - stage renal disease (ESRD), mortality, and other adverse events? … function measures Development of CKD, including end stage renal disease (ESRD) Rate of conversion … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage … renal disease; KQ=Key question; RRT=renal replacement therapy Figure 1b. … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage

31. Vascular Diseases | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/vascular-diseases
    August 16, 2010 - Research Protocol Archived May 17, 2013 Troponin Cardiac Marker Interpretation During Renal … Optimal Second-Line Therapy for Hypertension Abstract Archived January 1, 2005 Renal … Artery Stenosis Update Research Protocol Archived January 20, 2015 Renal Artery … Archived November 19, 2007 Comparative Effectiveness of Management Strategies for Renal … Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage

32. Nephropathy-Contrast-Induced Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
    October 01, 2013 - stage renal disease (ESRD), mortality, and other adverse events? … function measures ● Development of CKD, including end stage renal disease (ESRD) ● Rate of conversion … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage … Because of their role as end-users, individuals are invited to serve as Key Informants and those who

33. Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
    August 11, 2014 - discuss Food and Drug Administration (FDA) approval for troponin T for prognosis in patients with end-stage … Yes, the introduction is a bit long but hopefully sets the stage for how complex troponin interpretation … Table G was results for non-dialysis CKD patients (generally CKD stages 1-4, or stage 5 not on dialysis … We added the following statements to the end of the Data Analysis and Synthesis section of the main … didn’t make sense, the first in the last paragraph of the conclusion on page 119 (similarly at the end

34. Topic Brief: Patient Activation in Chronic Kidney Disease (pdf file)
    effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-chronic-kidney-disease.pdf
    June 01, 2021 - Issue: Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are prevalent and require significant … Chronic kidney disease can progress to kidney failure, also known as end-stage renal disease (ESRD). … Search strategy "renal insufficiency, chronic"[MeSH Terms] OR "chronic kidney disease"[All Fields] OR … Abbreviations: AHRQ=Agency for Healthcare Research and Quality; CKD=chronic kidney disease; ESRD=end- … stage renal disease Abbreviations: CKD=chronic kidney disease; PAM=patient activation measure; PICOS

35. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
    May 07, 2010 - The system can be triggered by sympathetic stimulation, renal artery hypotension, and decreased sodium … used extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal … events [MI], heart failure, cerebral vascular disease or events, symptomatic coronary artery disease, end-stage … failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … current search strategy and initial number of abstracts to be included in our abstract screening stage

36. Comparative Effectiveness of β-Adrenergic Antagonists on the Risk of Rehospitalization in Adults with Heart Failure (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
    November 01, 2007 - having an outpatient diagnosis for dyslipidemia and/or receipt of a lipid-lowering medication.(27) End-stage … - stage renal disease/chronic renal failure, chronic lung disease, known atrial fibrillation or flutter … angina or coronary artery disease, prior stroke or transient ischemic attack, diagnosed hypertension, end-stage … no β-blocker) Dyslipidemia 4,754(41.7) 3,791(47.2) 963(28.6) <0.001 End-stage renal disease or chronic … Identified from Kaiser End-Stage Renal Disease Treatment Registry which includes patients receiving

37. Topic Suggestion Description | Effective Health Care Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/chronic-kidney-disease
    December 02, 2020 - With the rapid growth in the number of Americans who face chronic kidney disease (CKD) and end-stage … renal disease (ESRD), more time and resources are being poured into the health care system to serve increasing

38. Bladder-Cancer-Muscle-Invasive Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
    June 01, 2015 - stage cancers invade beyond the muscle layer into surrounding fat (stage classification T3 bladder … For example, medically frail patients with baseline renal insufficiency may not be ideal candidates … for cisplatin-based therapy because of potential renal toxicity. … Surveillance Epidemiology and End Results. … patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End

39. Diabetes Medications for Adults with Type 2 Diabetes: An Update Focused on Monotherapy and Add-on Therapy to Metformin | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research-protocol
    January 22, 2015 - cardiovascular-related death nearly two-fold and is the leading cause of new-onset blindness and new-onset end-stage … not include studies where everyone included has at least one of the following comorbid conditions: End-stage … liver disease or cirrhosis End-stage renal disease (i.e., stage 5 chronic kidney disease or dialysis … Inclusion and exclusion criteria PICOTS Inclusion criteria Exclusion criteria ESLD = end-stage … liver disease; ESRD = end-stage renal disease; KQ = Key Question; RCT = randomized controlled trial

40. Treatment for Restless Legs Syndrome | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/restless-legs/research
    November 27, 2012 - No studies enrolled pregnant women, children, or those with end-stage renal disease.